Wolfe Research Initiates Coverage On Taysha Gene Therapies with Outperform Rating
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsInitiation
Wolfe Research analyst Kalpit Patel initiates coverage on Taysha Gene Therapies (NASDAQ:TSHA) with a Outperform rating.
Wolfe Research analyst Kalpit Patel initiates coverage on Taysha Gene Therapies (NASDAQ:TSHA) with a Outperform rating.